Low Dose Abdonminal Radiotherapy as a Taxotere Chemosensitizer for Recurrent/Persistent or Advanced Ovarian Carcinoma

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/024/30/04

Funding

  • Aventis Pharmaceuticals Products Inc: $7,538.00